Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Top Cited Papers
- 1 August 2020
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 396 (10247) , 313-319
- https://doi.org/10.1016/s0140-6736(20)31304-0
Abstract
No abstract availableAll Related Versions
This publication has 13 references indexed in Scilit:
- Estimates of the severity of coronavirus disease 2019: a model-based analysisThe Lancet Infectious Diseases, 2020
- Characteristics of Household Transmission of COVID-19Clinical Infectious Diseases, 2020
- Can an effective SARS-CoV-2 vaccine be developed for the older population?Immunity & Ageing, 2020
- Defining the Epidemiology of Covid-19 — Studies NeededNew England Journal of Medicine, 2020
- Why is it difficult to accurately predict the COVID-19 epidemic?Infectious Disease Modelling, 2020
- Thirteen‐year trends in the prevalence of diabetes in an urban region of Switzerland: a population‐based studyDiabetic Medicine, 2019
- Stan: A Probabilistic Programming LanguagePublished by Foundation for Open Access Statistic ,2017
- Eleven-year physical activity trends in a Swiss urban areaPreventive Medicine, 2014
- High prevalence of forgoing healthcare for economic reasons in Switzerland: A population-based study in a region with universal health insurance coveragePreventive Medicine, 2012
- Multilevel Modeling for Binary DataAnnual Review of Sociology, 2000